Home LiteratureArticle Details
PMID: 8459037 Published · ppublish English Journal Article

Proliferative activity of urothelial neoplasms: comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions.

Journal of clinical pathology ·Vol. 46 ·No. 2 ·1993-02-00 ·Pages 159-65

Limas C, Bigler A, Bair R, Bernhart P, Reddy P

Abstract

To evaluate the proliferative activity of urothelial neoplasms, compare it with that of the normal urinary tract epithelium, and determine its relation to morphological grade and presence of invasion. Multiple biopsy specimens from 53 individuals--eight normal controls, five patients with severe urothelial atypia, and 40 with transitional cell carcinomas (TCCs)--were studied using in vitro bromodeoxyuridine (BrdU) incorporation, Ki67 antigen expression, and quantitation of the nucleolar organiser regions (NORs). The percentage of nuclei labelled by BrdU (BrdU index) correlated well with the percentage of nuclei expressing the Ki67 antigen (Ki67 index). These proliferation indices were very low (less than 0.1% in 60% of samples) in the urothelium of normal controls and the morphologically unremarkable epithelium of patients with TCCs. Non-invasive TCCs had increased proliferation (BrdU index 6.32 (SD 0.8)%, Ki67 index 5.04 (0.6)% but lagged behind the invasive tumours (BrdU 20.9 (3.2)%, Ki67 18.6 (2.8)%). The average NOR count was 1.57 (0.03) in morphological normal epithelium, which increased progressively with grade in non-invasive TCCs, but varied greatly in invasive tumours and did not correlate with the proliferation indices. The spectrum of values for both proliferation indices and NORs was particularly wide in grade 2 TCCs. Severe atypias without exophytic growth had an increase in BrdU and Ki67 indices comparable with that found in grade 3-4 invasive TCCs; these also had the highest NORs per nucleus. The growth potential of urothelial neoplasms is an important indicator of their aggressive course. In particular, growth indices over 10% are strongly associated with the presence of invasion. Papillary grade 2 TCCs show heterogeneity in their growth characteristics which may relate to their diverse clinical course. The mitotic count underestimates the growth potential of papillary TCCs and the addition of proliferation indices such as BrdU incorporation or the Ki67 index may enhance the prognostic accuracy of conventional morphological grading.

MeSH Terms
Antigens, Neoplasm/analysis Bromodeoxyuridine/metabolism Carcinoma, Transitional Cell/pathology Cell Count Cell Division Humans Ki-67 Antigen Middle Aged Mitotic Index Neoplasm Proteins/analysis Nuclear Proteins/analysis Nucleolus Organizer Region/pathology Prognosis Urinary Bladder Neoplasms/metabolism,pathology
Chemicals
Antigens, Neoplasm Ki-67 Antigen Neoplasm Proteins Nuclear Proteins Bromodeoxyuridine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Limas C
Department of Pathology, VA Medical Center, Minneapolis, MN 55417.
Bigler A
Bair R
Bernhart P
Reddy P
References (17)
17 references, click to expand
  1. Visualization of nucleolar organizer regions im mammalian chromosomes using silver staining.
    Chromosoma. 1975 Nov 20;53(1):37-50 PMID: 53131
  2. NATURAL HISTORY AND CLINICAL BEHAVIOR OF IN SITU CARCINOMA OF THE HUMAN URINARY BLADDER.
    Cancer. 1964 Dec;17:1533-45 PMID: 14239679
  3. The pathology of human bladder cancer.
    Cancer. 1980 Apr 15;45(7 Suppl):1823-31 PMID: 7370933
  4. Controlled silver-staining of nucleolus organizer regions with a protective colloidal developer: a 1-step method.
    Experientia. 1980 Aug 15;36(8):1014-5 PMID: 6160049
  5. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication.
    Science. 1982 Oct 29;218(4571):474-5 PMID: 7123245
  6. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.
    Int J Cancer. 1983 Jan 15;31(1):13-20 PMID: 6339421
  7. Proliferative activity of urothelium and tumors of renal pelvis, ureter, and urinary bladder evaluated by thymidine labeling.
    Urology. 1984 Mar;23(3 Suppl):15-22 PMID: 6367190
  8. Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67.
    Hematol Oncol. 1984 Oct-Dec;2(4):365-71 PMID: 6396192
  9. Nucleolar organizer regions in lymphomas.
    J Pathol. 1987 Feb;151(2):111-8 PMID: 2437276
  10. Evaluation of nucleolar organizer region-associated proteins in breast malignancy.
    Histopathology. 1988 Feb;12(2):113-25 PMID: 2452777
  11. Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count.
    Cancer. 1990 Mar 1;65(5):1180-4 PMID: 2406010
  12. Role of nucleolar organiser regions in differentiating malignant from benign tumours of the colon.
    J Clin Pathol. 1990 Mar;43(3):235-8 PMID: 2332519
  13. Proliferation rate of colonic mucosa in normal subjects and patients with colonic neoplasms: a refined immunohistochemical method.
    J Clin Pathol. 1990 Jun;43(6):453-6 PMID: 2380393
  14. Cell cycling in bladder carcinoma determined by monoclonal antibody Ki67.
    Br J Urol. 1990 Sep;66(3):281-5 PMID: 2207543
  15. Monoclonal antibody Ki-67: its use in histopathology.
    Histopathology. 1990 Dec;17(6):489-503 PMID: 2076881
  16. Intra-urothelial cancer: carcinoma in situ, Bowen's disease of the urinary system: discussion of thirty cases.
    J Urol. 1952 Oct;68(4):763-72 PMID: 12991388
  17. A, B, H antigens in transitional cell tumors of the urinary bladder: correlation with the clinical course.
    Cancer. 1979 Dec;44(6):2099-107 PMID: 509389
Article Info
Journal
Journal of clinical pathology
Abbr.
J Clin Pathol
ISSN
0021-9746
Published
1993-02-00
Pages
159-65
Language
English
Region
England
NLM ID
0376601
PMCID
PMC501149
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]